AMAG PHARMACEUTICALS INC's ticker is and the CUSIP is 00163UAA4. A total of 28 filers reported holding AMAG PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $7,206,000 | -3.5% | 7,424,000 | 0.0% | 3.24% | +9.2% |
Q3 2018 | $7,467,000 | -3.7% | 7,424,000 | 0.0% | 2.97% | -20.7% |
Q2 2018 | $7,757,000 | -1.8% | 7,424,000 | 0.0% | 3.74% | -9.6% |
Q1 2018 | $7,901,000 | +6.4% | 7,424,000 | 0.0% | 4.14% | -8.9% |
Q4 2017 | $7,424,000 | -5.9% | 7,424,000 | 0.0% | 4.54% | -7.2% |
Q3 2017 | $7,888,000 | +1.8% | 7,424,000 | 0.0% | 4.89% | +4.8% |
Q2 2017 | $7,748,000 | -45.2% | 7,424,000 | -25.8% | 4.66% | -62.4% |
Q4 2016 | $14,144,000 | -27.8% | 10,000,000 | -42.0% | 12.41% | -32.5% |
Q3 2016 | $19,597,000 | +2.4% | 17,250,000 | 0.0% | 18.38% | +82.5% |
Q2 2016 | $19,146,000 | – | 17,250,000 | – | 10.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Birch Grove Capital LP | 17,250,000 | $19,597,000 | 18.38% |
STEELHEAD PARTNERS LLC | 17,000,000 | $19,264,000 | 1.88% |
Bruce & Co., Inc. | 5,500,000 | $6,600,000 | 1.78% |
STELLIAM INVESTMENT MANAGEMENT, LP | 26,750,000 | $30,177,000 | 1.01% |
Castle Creek Arbitrage, LLC | 3,721,000 | $4,215,000 | 0.43% |
LINDEN ADVISORS LP | 7,000,000 | $7,909,000 | 0.36% |
Sonora Investment Management, LLC | 1,510,000 | $1,702,676,000 | 0.36% |
BASSO CAPITAL MANAGEMENT, L.P. | 2,110,000 | $2,382,000 | 0.35% |
WOLVERINE ASSET MANAGEMENT LLC | 18,400,000 | $20,808,000 | 0.31% |
SSI INVESTMENT MANAGEMENT LLC | 1,975,000 | $2,221,000 | 0.20% |